One-Year Follow-Up of Acne Vulgaris Patients Treated With Nonablative Monopolar Radiofrequency: Efficacy and Safety Assessment

Nonablative monopolar radiofrequency (NMRF) therapy has been shown to be a safe and effective long-term treatment for moderate-to-severe acne vulgaris, with sustained reductions in both inflammatory and noninflammatory lesion counts and sebum production up to 12 months posttreatment. In a study involving 20 participants, 11 completed the 12-month follow-up, revealing significant decreases in papules, pustules, nodules, and cysts, along with high patient satisfaction and no significant adverse effects. This suggests NMRF as a promising minimally invasive alternative for managing acne vulgaris.